Methods of synthesizing aztreonam derivatives
US11565999B2 · kind B2 · utility
0Cited by
14References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2020 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Apr 6, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, and methods of synthesizing aztreonam derivatives. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.